Cargando…

BRCA2 Promotes Spontaneous Homologous Recombination In Vivo

SIMPLE SUMMARY: Inherited mutation of either BRCA1 or BRCA2 is associated with familial breast and ovarian cancer. As a tumor suppressor, BRCA2 functions to maintain genome stability but we do not know the genomic impact of this deficiency on normal tissues in normal contexts, rather than cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Adam D., Greenman, Scott, Claybon, Alison B., Bishop, Alexander J. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345144/
https://www.ncbi.nlm.nih.gov/pubmed/34359565
http://dx.doi.org/10.3390/cancers13153663
_version_ 1783734559480741888
author Brown, Adam D.
Greenman, Scott
Claybon, Alison B.
Bishop, Alexander J. R.
author_facet Brown, Adam D.
Greenman, Scott
Claybon, Alison B.
Bishop, Alexander J. R.
author_sort Brown, Adam D.
collection PubMed
description SIMPLE SUMMARY: Inherited mutation of either BRCA1 or BRCA2 is associated with familial breast and ovarian cancer. As a tumor suppressor, BRCA2 functions to maintain genome stability but we do not know the genomic impact of this deficiency on normal tissues in normal contexts, rather than cancer cells that carry other gene mutations. Numerous murine models of BRCA2 have been developed to investigate BRCA2 tumor suppressor function but have been met with difficulties due to the lethality of most of these models during embryogenesis. To circumvent embryonic lethality here, we employ the cre conditional system combined with an assay for measuring changes in stability of a large tandem DNA repeat by homology-directed recombination. The relevance of this assay is that it can measure DNA recombination events in a normal growing/developing tissue. Here, we show that BRCA2 is required for homologous recombination in a normal developing tissue long before cancer arises. ABSTRACT: Background: BRCA2 is known to be a tumor suppressor involved in homologous recombination repair and presumed to prevent genome instability in normal tissues prior to the development of tumors. Typical assessment of BRCA2 deficiency on the genome involves cell-based models using cancer cells with mixed genetic contexts, but the role in normal tissue in vivo has not been clearly demonstrated. Methods: Using conditional deletion of Brca2 exon 11, the region containing all eight BRC repeats, in the retinal pigment epithelium and the pink-eyed unstable mouse model, we evaluate the frequency of DNA deletion events. Results: In the current study, we show that conditional loss of Brca2 exon 11 results in a decreased frequency of spontaneous homologous recombination compared to wild-type mice. Of note, we observe no apparent concomitant increase in events that indicate single-strand annealing by the pink-eyed unstable mouse model. Conclusions: Therefore, our results demonstrate that BRCA2, as expected, is required for high-fidelity homologous recombination DNA repair in normal tissues, here in a tissue undergoing normal proliferation through normal development.
format Online
Article
Text
id pubmed-8345144
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83451442021-08-07 BRCA2 Promotes Spontaneous Homologous Recombination In Vivo Brown, Adam D. Greenman, Scott Claybon, Alison B. Bishop, Alexander J. R. Cancers (Basel) Article SIMPLE SUMMARY: Inherited mutation of either BRCA1 or BRCA2 is associated with familial breast and ovarian cancer. As a tumor suppressor, BRCA2 functions to maintain genome stability but we do not know the genomic impact of this deficiency on normal tissues in normal contexts, rather than cancer cells that carry other gene mutations. Numerous murine models of BRCA2 have been developed to investigate BRCA2 tumor suppressor function but have been met with difficulties due to the lethality of most of these models during embryogenesis. To circumvent embryonic lethality here, we employ the cre conditional system combined with an assay for measuring changes in stability of a large tandem DNA repeat by homology-directed recombination. The relevance of this assay is that it can measure DNA recombination events in a normal growing/developing tissue. Here, we show that BRCA2 is required for homologous recombination in a normal developing tissue long before cancer arises. ABSTRACT: Background: BRCA2 is known to be a tumor suppressor involved in homologous recombination repair and presumed to prevent genome instability in normal tissues prior to the development of tumors. Typical assessment of BRCA2 deficiency on the genome involves cell-based models using cancer cells with mixed genetic contexts, but the role in normal tissue in vivo has not been clearly demonstrated. Methods: Using conditional deletion of Brca2 exon 11, the region containing all eight BRC repeats, in the retinal pigment epithelium and the pink-eyed unstable mouse model, we evaluate the frequency of DNA deletion events. Results: In the current study, we show that conditional loss of Brca2 exon 11 results in a decreased frequency of spontaneous homologous recombination compared to wild-type mice. Of note, we observe no apparent concomitant increase in events that indicate single-strand annealing by the pink-eyed unstable mouse model. Conclusions: Therefore, our results demonstrate that BRCA2, as expected, is required for high-fidelity homologous recombination DNA repair in normal tissues, here in a tissue undergoing normal proliferation through normal development. MDPI 2021-07-21 /pmc/articles/PMC8345144/ /pubmed/34359565 http://dx.doi.org/10.3390/cancers13153663 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Brown, Adam D.
Greenman, Scott
Claybon, Alison B.
Bishop, Alexander J. R.
BRCA2 Promotes Spontaneous Homologous Recombination In Vivo
title BRCA2 Promotes Spontaneous Homologous Recombination In Vivo
title_full BRCA2 Promotes Spontaneous Homologous Recombination In Vivo
title_fullStr BRCA2 Promotes Spontaneous Homologous Recombination In Vivo
title_full_unstemmed BRCA2 Promotes Spontaneous Homologous Recombination In Vivo
title_short BRCA2 Promotes Spontaneous Homologous Recombination In Vivo
title_sort brca2 promotes spontaneous homologous recombination in vivo
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345144/
https://www.ncbi.nlm.nih.gov/pubmed/34359565
http://dx.doi.org/10.3390/cancers13153663
work_keys_str_mv AT brownadamd brca2promotesspontaneoushomologousrecombinationinvivo
AT greenmanscott brca2promotesspontaneoushomologousrecombinationinvivo
AT claybonalisonb brca2promotesspontaneoushomologousrecombinationinvivo
AT bishopalexanderjr brca2promotesspontaneoushomologousrecombinationinvivo